Development of novel potent ligands for GPR85 , an orphan G protein‐coupled receptor expressed in the brain
Genes to Cells · 2022-05 · 27 (5) · 345-355
DOI: 10.1111/gtc.12931 ↗Kurz gefasst
Fachartikel in der Zeitschrift Genes to Cells, 2022-03. Verfasst von Aya Sakai und 9 weiteren Autor:innen. Beteiligte Einrichtung: Graduate of School of Science and Technology, Division of Molecular Science, Gunma University, Gunma, Japan. Hauptthemen laut MEDLINE: Brain. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 18 Literaturangaben. Gefördert von: AMED, Gunma University Medical Innovation Project, Japan Agency for Medical Research and Development.
Abstract (Originalsprache)
GPR85 is a member of the G protein‐coupled receptor and is a super‐conserved receptor expressed in the brain sub‐family (Super Conserved Receptor Expressed in Brain; SREB) with GPR27 and GPR173. These three receptors are “orphan receptors”; however, their endogenous ligands have not been identified. SREB has garnered the interest of many scientists because it is expressed in the central nervous system and is evolutionarily conserved. In particular, brain mass is reported to be increased and learning and memory are improved in GPR85 knockout mice (Matsumoto et al. 2008). In this study, we characterized newly synthesized compounds using a GPR85‐Gsα fusion protein and the [ 35 S]GTPγS binding assay and identified novel GPR85 inverse‐agonists with IC 50 values of approximately 1 μM. To analyze the neurochemical character of the compounds and investigate the physiological significance of GPR85, we used cerebellar Purkinje cells expressing GPR85 and an electrophysiological technique. Based on the results, the inverse‐agonist compound for GPR85 modulated potassium channel opening. Together with the results of previous gene analysis of GPR85, we expect that the development of the GPR85 ligand will provide new insights into a few types of neurological disorders.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Graduate of School of Science and Technology, Division of Molecular Science, Gunma University, Gunma, Japan.
- Graduate of School of Pharmaceutical Sciences, Department of Basic Medicinal Sciences, Graduate School of Pharmaceutical Sciences, Nagoya University, Nagoya, Japan.
- Graduate School of Medicine, Department of Neurophysiology and Neural Repair, Gunma University, Maebashi, Japan.
ORCID-Profile: Shigeki Takeda
Förderung
- AMED
- Gunma University Medical Innovation Project
- Japan Agency for Medical Research and Development
Zitieren
APA
Sakai, A., Yasui, T., Watanave, M., Tatsumi, R., Yamamoto, Y., Takano, W., Tani, Y., Okamura, I., Hirai, H., & Takeda, S. (2022). Development of novel potent ligands for GPR85 , an orphan G protein‐coupled receptor expressed in the brain. Genes to Cells, 27(5), 345-355. https://doi.org/10.1111/gtc.12931
Vancouver
Sakai A, Yasui T, Watanave M, Tatsumi R, Yamamoto Y, Takano W, et al. Development of novel potent ligands for GPR85 , an orphan G protein‐coupled receptor expressed in the brain. Genes to Cells. 2022;27(5):345-355. doi:10.1111/gtc.12931
BibTeX
@article{Sakai2022,
author = {Sakai, Aya and Yasui, Takeshi and Watanave, Masashi and Tatsumi, Rine and Yamamoto, Yoshihiko and Takano, Wataru and Tani, Yuki and Okamura, Izumi and Hirai, Hirokazu and Takeda, Shigeki},
title = {Development of novel potent ligands for GPR85 , an orphan G protein‐coupled receptor expressed in the brain},
journal = {Genes to Cells},
year = {2022},
volume = {27},
number = {5},
pages = {345--355},
doi = {10.1111/gtc.12931}
}
EUVIMED